Search results

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.

Result type

NICE guideline

Last updated

26 February 2026

Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults.

Result type

Technology appraisal guidance

Published

22 June 2016

people admitted to hospital with suspected non-ST-segment-elevation myocardial infarction. Cash savings: £100 Capacity savings: £24,800...

Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting in adults. This involves reversing blood flow away from the brain and filtering the blood to remove any debris.

Result type

HealthTech guidance

Published

22 June 2016

Discontinued Reference number: GID-TA10337

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on thoracoscopically assisted mitral valve surgery. This involves repairing a defective valve through one or more small incisions between the ribs rather than one large incision through the breastbone (sternum).

Result type

HealthTech guidance

Published

12 December 2007

device durability; and the complications of hypertension, such as myocardial infarction and stroke. Any explanatory notes(if applicable)...

Result type

Research recommendation

Published

9 December 2015

complications in the longer term. This includes an increased risk of myocardial infarction and death with some types of bioresorbable...

Result type

Research recommendation

Published

7 September 2022

Evidence-based recommendations on intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary intervention. This involves using ultrasound shockwaves to break up hard deposits in the arteries, to allow blood to flow more freely.

Result type

HealthTech guidance

Published

5 February 2025

Evidence-based recommendations on cryoablation for atrial fibrillation in association with other cardiac surgery. This involves using a probe to freeze the heart tissue to scar it and interrupt the abnormal electrical signals.

Result type

HealthTech guidance

Published

25 May 2005

Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.

Result type

Technology appraisal guidance

Last updated

2 July 2021

NICE has developed a medtech innovation briefing (MIB) on CytoSorb for reducing risk of bleeding during cardiac surgery .

Result type

Medtech innovation briefing

Published

2 February 2021

Evidence-based recommendations on adefovir dipivoxil (Hepsera) and peginterferon alfa-2a (Pegasys) for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

22 February 2006

Evidence-based recommendations on valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) for aortic bioprosthetic valve dysfunction in adults. This involves placing a new bioprosthetic valve inside a failing bioprosthetic valve.

Result type

HealthTech guidance

Published

26 June 2019

Evidence-based recommendations on evolocumab (Repatha) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults.

Result type

Technology appraisal guidance

Published

22 June 2016